Literature DB >> 24737132

Combination of MRI and dynamic FET PET for initial glioma grading.

V Dunet1, P Maeder, M Nicod-Lalonde, B Lhermitte, C Pollo, J Bloch, R Stupp, R Meuli, J O Prior.   

Abstract

AIM: MRI and PET with 18F-fluoro-ethyl-tyrosine (FET) have been increasingly used to evaluate patients with gliomas. Our purpose was to assess the additive value of MR spectroscopy (MRS), diffusion imaging and dynamic FET-PET for glioma grading. PATIENTS,
METHODS: 38 patients (42 ± 15 aged, F/M: 0.46) with untreated histologically proven brain gliomas were included. All underwent conventional MRI, MRS, diffusion sequences, and FET-PET within 3±4 weeks. Performances of tumour FET time-activity-curve, early-to-middle SUVmax ratio, choline / creatine ratio and ADC histogram distribution pattern for gliomas grading were assessed, as compared to histology. Combination of these parameters and respective odds were also evaluated.
RESULTS: Tumour time-activity-curve reached the best accuracy (67%) when taken alone to distinguish between low and high-grade gliomas, followed by ADC histogram analysis (65%). Combination of time-activity-curve and ADC histogram analysis improved the sensitivity from 67% to 86% and the specificity from 63-67% to 100% (p < 0.008). On multivariate logistic regression analysis, negative slope of the tumour FET time-activity-curve however remains the best predictor of high-grade glioma (odds 7.6, SE 6.8, p = 0.022).
CONCLUSION: Combination of dynamic FET-PET and diffusion MRI reached good performance for gliomas grading. The use of FET-PET/MR may be highly relevant in the initial assessment of primary brain tumours.

Entities:  

Keywords:  18F-fluoro-ethyl-tyrosine; ADC histogram; MRI; glioma; grading

Mesh:

Substances:

Year:  2014        PMID: 24737132     DOI: 10.3413/Nukmed-0650-14-03

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  12 in total

Review 1.  PET/MRI of central nervous system: current status and future perspective.

Authors:  Zhen Lu Yang; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2016-01-15       Impact factor: 5.315

Review 2.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

Review 3.  Current status and future role of brain PET/MRI in clinical and research settings.

Authors:  P Werner; H Barthel; A Drzezga; O Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

Review 4.  The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.

Authors:  Qun Wang; Hui Zhang; JiaShu Zhang; Chen Wu; WeiJie Zhu; FangYe Li; XiaoLei Chen; BaiNan Xu
Journal:  Eur Radiol       Date:  2015-10-15       Impact factor: 5.315

Review 5.  Positron emission tomography of high-grade gliomas.

Authors:  Guido Frosina
Journal:  J Neurooncol       Date:  2016-02-20       Impact factor: 4.130

Review 6.  Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.

Authors:  Vincent Dunet; Anastasia Pomoni; Andreas Hottinger; Marie Nicod-Lalonde; John O Prior
Journal:  Neuro Oncol       Date:  2015-08-04       Impact factor: 12.300

Review 7.  PET/MRI in Oncological Imaging: State of the Art.

Authors:  Usman Bashir; Andrew Mallia; James Stirling; John Joemon; Jane MacKewn; Geoff Charles-Edwards; Vicky Goh; Gary J Cook
Journal:  Diagnostics (Basel)       Date:  2015-07-21

8.  The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET.

Authors:  Bogdan Malkowski; Maciej Harat; Agnieszka Zyromska; Tomasz Wisniewski; Aleksandra Harat; Rita Lopatto; Jacek Furtak
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

Review 9.  Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.

Authors:  Lisbeth Marner; Otto M Henriksen; Michael Lundemann; Vibeke Andrée Larsen; Ian Law
Journal:  Clin Transl Imaging       Date:  2016-11-18

Review 10.  Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma.

Authors:  Gloria C Chiang; Ilhami Kovanlikaya; Changho Choi; Rohan Ramakrishna; Rajiv Magge; Dikoma C Shungu
Journal:  Front Neurol       Date:  2018-02-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.